利用心血管磁共振T1 mapping评估淤血性肝病
本研究回顾性纳入172例受试者(140例心功能正常、16例法洛四联症修复术后、16例Fontan姑息术后),通过心血管磁共振(CMR)注射钆对比剂前后MOLLI T1 mapping计算肝脏细胞外容积(ECV)。心功能正常组与Fontan姑息组肝脏原生T1和ECV差异有统计学意义(p < 0.01)。作者认为注射前后T1 mapping可用于随访肝纤维化进展。
要点
- 心功能正常组与Fontan姑息组肝脏原生T1和ECV差异有统计学意义(p < 0.01)。
- CMR注射钆对比剂前后行MOLLI T1 mapping可计算肝脏ECV。
- 作者认为该技术可用于随访肝纤维化进展。
核心结论
- 心功能正常患者与Fontan姑息患者之间肝脏原生T1和ECV测量值差异有统计学意义(p < 0.01);在CMR检查中于注射钆对比剂前后测量T1图可用于随访肝纤维化进展,该技术有潜力改善慢性肝病和肝纤维化患者的诊断与治疗。
研究设计与样本
- 回顾性研究,纳入三个队列共172例受试者:心功能正常140例、法洛四联症修复术后16例、Fontan姑息术后16例;所有CMR检查均包含注射钆对比剂前后进行的改良Look-Locker反转恢复(MOLLI)T1 mapping扫描;从肝脏和心脏血池图像手动采集像素强度数据以确定对比剂引起的T1变化,并计算肝脏ECV。
诊断标准与关键数值
- 心功能正常组与Fontan姑息组之间肝脏原生T1和ECV测量值差异有统计学意义(p < 0.01)。
临床应用与阅片要点
- 作者认为,在CMR检查中于注射钆对比剂前后测量T1图可用于随访肝纤维化进展。
- 作者认为,该技术有潜力改善慢性肝病和肝纤维化患者的诊断与治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The goal of this study was to assess the ability of quantitative T1 cardiovascular magnetic resonance (CMR) imaging to calculate liver extracellular volume (ECV) in patients with varying degrees of congestive hepatopathy (CH). T1 measurements and ECV calculations were performed retrospectively in three cohorts of patients: normal cardiac function, tetralogy of fallot (TOF) repair and Fontan palliation. All CMR studies included modified look-locker inversion recovery (MOLLI) T1 mapping scans performed pre- and post-injection of a gadolinium-based contrast agent (GBCA). Pixel intensity data were manually collected from images of the liver and cardiac blood pool to determine contrast-induced changes in T1 for liver and blood. These data were then used to compute liver ECV. 172 subjects were included in the study. Of these, 140 subjects were normal cardiac function patients, 16 were TOF repair patients and 16 patients were with Fontan palliation. A statistically significant difference in both the liver native T1 and ECV measurements was found between patients with normal cardiac function vs. Fontan palliation patients (p < 0.01). Our data indicate that measuring T1 maps both pre- and post-GBCA injection within CMR scan session can be used to follow progression of liver fibrosis. This technique has the potential to improve diagnosis and treatment of patients with chronic liver disease and liver fibrosis.
引用
- Kazour I, Serai SD, Xanthakos SA, et al. Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY). 2018. PMID: 29500649. doi:10.1007/s00261-018-1528-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。